RxDoctor Payments Data

Elizabeth Kohan

Nurse Practitioner · New York, NYNPI 1811396021

Payments from drug & device makers

$6,251in general payments, 2019–2025

Across 185 payments — averaging $33.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Boston Scientific$1K
  • Insightec,inc$1K
  • Amneal Pharmaceuticals LLC$892
  • AbbVie$348
  • Neurocrine Biosciences, Inc.$231
  • plus $654 from 6 others

What the payments were for

  • Speaking & faculty fees$1502%
  • Travel & lodging$2,24436%
  • Food & beverage$3,85662%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,251 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
GocovriAmantadine Hcl97$307,745
NuplazidPimavanserin Tartrate58$304,098
RytaryCarbidopa/Levodopa67$111,050
NeuproRotigotine15$20,785
OngentysOpicapone20$18,316
Carbidopa-LevodopaCarbidopa/Levodopa271$9,865
Rasagiline Mesylate27$8,861
Carbidopa-Levodopa ErCarbidopa/Levodopa59$4,166
Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone16$3,986
AmantadineAmantadine Hcl54$2,887
Rivastigmine15$2,341
Propranolol Hcl ErPropranolol Hcl14$1,293
Pramipexole DihydrochloridePramipexole Di-Hcl41$557
Trihexyphenidyl Hcl26$503
Gabapentin28$410

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MDD US Operations, LLCGocovri$195$307,74597 claims
Acadia Pharmaceuticals IncNuplazid$214$304,09858 claims
Amneal Pharmaceuticals LLCRytary$892$111,05067 claims
Neurocrine Biosciences, Inc.Ongentys$231$18,31620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,112 nurse practitioner providers in New York.

Other nurse practitioner in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →